Related Experiment Videos
Thin glomerular basement membrane disease
G M Frascá1, A Onetti-Muda, A Renieri
1Nephrology and Dialysis Unit, St. Orsola Hospital, Bologna, Italy. frasca@orsola-malpighi.med.unibo.it
Abstract:
The term thin glomerular basement membrane disease (TBMD) refers to a condition characterised by thinning of the GBM at electron microscopy examination and, clinically, by isolated hematuria, frequently occurring in other family members, with no extra-renal manifestations. Progression towards chronic renal failure (CRF), although rare, has been reported and blood pressure is high in 30-35% of cases during follow-up. TBMD is generally considered different from Alport syndrome since immunohistological investigation does not show abnormalities of type IV collagen alpha chains in the GBM, as frequently observed in Alport patients; moreover, in familial cases, the disease is transmitted as autosomal dominant trait, rarely observed in Alport syndrome. Genetic studies suggest that TBMD is a heterogeneous disease, but some cases may be related to mutations of COL4A3/COL4A4 genes, thus belonging to the spectrum of type IV collagen diseases. TBMD may arise with other glomerular diseases, most frequently IgA nephropathy, and it remains to be established whether these cases are a casual occurrence or whether a thinner than normal GBM predisposes to immune complex deposition.
Insights
Thin glomerular basement membrane disease (TBMD) is characterized by GBM thinning and isolated hematuria. While generally distinct from Alport syndrome, some TBMD cases may involve COL4A3/COL4A4 gene mutations.
Area of Science:
- Nephrology
- Genetics
- Pathology
Background:
- Thin glomerular basement membrane disease (TBMD) presents with GBM thinning on electron microscopy and isolated hematuria.
- It is often familial with an autosomal dominant inheritance pattern and typically lacks extra-renal manifestations.
- While usually benign, TBMD can rarely progress to chronic renal failure and is associated with hypertension in 30-35% of cases.
Purpose of the Study:
- To differentiate TBMD from Alport syndrome based on immunohistological findings and genetic transmission patterns.
- To investigate the genetic basis of TBMD, exploring its heterogeneity and potential links to COL4A3/COL4A4 gene mutations.
- To examine the association between TBMD and other glomerular diseases, particularly IgA nephropathy.
Main Methods:
- Electron microscopy for GBM assessment.
- Immunohistological analysis for type IV collagen alpha chain abnormalities.
- Genetic studies to identify mutations in COL4A3/COL4A4 genes.
- Clinical follow-up to assess disease progression and associated conditions.
Main Results:
- TBMD shows GBM thinning without the type IV collagen abnormalities typical of Alport syndrome.
- Familial TBMD often follows an autosomal dominant inheritance pattern.
- Some TBMD cases are linked to COL4A3/COL4A4 gene mutations, placing them within the spectrum of type IV collagen diseases.
- TBMD frequently co-occurs with other glomerular diseases like IgA nephropathy.
Conclusions:
- TBMD is a distinct entity from Alport syndrome, characterized by GBM thinning and specific genetic/immunohistological profiles.
- The genetic heterogeneity of TBMD is highlighted, with some cases related to COL4A3/COL4A4 gene mutations.
- The relationship between TBMD and co-existing glomerular diseases like IgA nephropathy requires further investigation to determine causality or predisposition.